Skip to main content

29-05-2020 | ASCO 2020 | Conference coverage | Video

Researcher comment: The KEYNOTE-604 trial

Charles Rudin reports on the phase 3 KEYNOTE-604 trial of pembrolizumab plus chemotherapy for extensive-stage small-cell lung cancer, putting the findings in context of the IMpower133 and CASPIAN studies (5:01).

Read transcript